Provides a comprehensive molecular profile that includes 49 clinically actionable genes associated with a broad spectrum of cancers. Includes: microsatellite instability (MSI), tumor mutational burden (TMB), and RNA for fusions.
The diagnosis and treatment of cancer is progressing rapidly—yet implementing these advancements can tax a health system’s limited resources. To help you stay ahead, Quest Advanced® offers a comprehensive portfolio of molecular testing and pathology solutions and services for solid tumors.
With advanced testing, medical expertise, technical solutions, and customer service, we can empower you to transform cancer care and deliver personalized insights to help drive actionable treatments for each individual patient.
Biomarkers are vital to understanding the full genetic makeup of a patient’s tumor, providing the information your clinicians need to make an accurate diagnosis and initiate appropriate cancer treatment.
We offer a comprehensive block retrieval program for when the sample is not on hand:
Contact our team 8:00 AM to 9:00 PM EST: